The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Liquid Biopsy: From Discovery to Clinical Application
Abstract
Over the past 10 years, circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) have received enormous attention as new biomarkers and subjects of translational research. Although both biomarkers are already used in numerous clinical trials, their clinical utility is still under investigation with promising first results. Clinical applications include early cancer detection, improved cancer staging, early detection of relapse, real-time monitoring of therapeutic efficacy, and detection of therapeutic targets and resistance mechanisms. Here, we propose a conceptual framework of CTC and ctDNA assays and point out current challenges of CTC and ctDNA research, which might structure this dynamic field of translational cancer research. Significance: The analysis of blood for CTCs or cell-free nucleic acids called “liquid biopsy” has opened new avenues for cancer diagnostics, including early detection of tumors, improved risk assessment and staging, as well as early detection of relapse and monitoring of tumor evolution in the context of cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · cited 1×
“Even if one metastatic lesion can be biopsied, substantial genetic heterogeneity of metastatic lesions located at different sites in the same patient has been demonstrated (111).”
BackgroundTumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101 · cited 1×
“Nucleic acids and proteins transported in exosomes from primary lesions to distant sites can be taken up by recipient cells and change tumor biology (150, 151).”
BackgroundSelf-citationIsolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531 · cited 1×
“Technical advances have made ctDNA assays much more specific, but recent reports demonstrate that aging individuals show a background of mutations including cancer driver genes (53, 54).”
BackgroundCell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Self-citationDetection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136 · cited 1×
“Data obtained in mouse models (59) and patients with cancer (60, 61) indicate that blood-borne dissemination of cancer cells occurs early during tumor development, which provided the rationale to explore CTCs as marker for early detection of cancer.”
BackgroundIsolation of circulating tumor cells using a microvortex-generating herringbone-chip
Stott, S. L., Hsu, C.-H., Tsukrov, D. I., Yu, M., Miyamoto, D. T., Waltman, B. A., Rothenberg, S. M., Shah, A. M., Smas, M. E., Korir, G. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012539107 · Cited by 1,634
Current and future perspectives of liquid biopsies in genomics-driven oncology
Heitzer, E., Haque, I. S., Roberts, C. E. S., & Speicher, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0071-5 · Cited by 1,557
Liu, M. C., Oxnard, G. R., Klein, E. A., Swanton, C., Seiden, M. V., Liu, M. C., Oxnard, G. R., Klein, E. A., Smith, D., Richards, D., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.02.011 · Cited by 1,495
Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6219 · Cited by 1,492 · cited 1×
“Encouraging results were also obtained in colorectal (94) and lung (95) cancers as two other major cancer types.”
ResultGenome-wide cell-free DNA fragmentation in patients with cancer
Cristiano, S., Leal, A., Phallen, J., Fiksel, J., Adleff, V., Bruhm, D. C., Jensen, S. Ø., Medina, J. E., Hruban, C., White, J. R., et al. (2019) · Nature · doi:10.1038/s41586-019-1272-6 · Cited by 1,476
Challenges in circulating tumour cell research
Alix-Panabières, C., & Pantel, K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3820 · Cited by 1,300
Self-citationExosome-Mediated Metastasis: Communication from a Distance
Wortzel, I., Dror, S., Kenific, C. M., & Lyden, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.011 · Cited by 1,285
Characteristics and Significance of the Pre-metastatic Niche
Liu, Y., & Cao, X. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.011 · Cited by 1,269
Systemic Spread Is an Early Step in Breast Cancer
Hüsemann, Y., Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., Forni, G., Eils, R., Fehm, T., Riethmüller, G., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.003 · Cited by 1,188
Gandara, D. R., Paul, S. M., Kowanetz, M., Schleifman, E., Zou, W., Li, Y., Rittmeyer, A., Fehrenbacher, L., Otto, G., Malboeuf, C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0134-3 · Cited by 1,157
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R. J., Cheang, M., Osin, P., Nerurkar, A., Kozarewa, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0021 · Cited by 1,150
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Pantel, K., & Alix-Panabières, C. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0187-3 · Cited by 1,110
Self-citationClonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3870 · Cited by 1,082
Chaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., Khodadoust, M. S., Esfahani, M. S., Liu, C. L., Zhou, L., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0716 · Cited by 1,072
Ganesh, K., & Massagué, J. (2021) · Nature Medicine · doi:10.1038/s41591-020-01195-4 · Cited by 1,051
Baccelli, I., Schneeweiss, A., Riethdorf, S., Stenzinger, A., Schillert, A., Vogel, V., Klein, C., Saini, M., Bäuerle, T., Wallwiener, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2576 · Cited by 1,047
Self-citationEx vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Yu, M., Bardia, A., Aceto, N., Bersani, F., Madden, M. W., Donaldson, M. C., Desai, R., Zhu, H., Comaills, V., Zheng, Z., et al. (2014) · Science · doi:10.1126/science.1253533 · Cited by 913
Krebs, M. G., Sloane, R., Priest, L., Lancashire, L., Hou, J.-M., Greystoke, A., Ward, T. H., Ferraldeschi, R., Hughes, A., Clack, G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7045 · Cited by 868
Hou, J.-M., Krebs, M. G., Lancashire, L., Sloane, R., Backen, A., Swain, R. K., Priest, L. J. C., Greystoke, A., Zhou, C., Morris, K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3716 · Cited by 842
Bidard, F.-C., Peeters, D. J., Fehm, T., Nolé, F., Gisbert-Criado, R., Mavroudis, D., Grisanti, S., Generali, D., Garcia-Saenz, J. A., Stebbing, J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70069-5 · Cited by 838
Self-citationCirculating tumour cells in cancer patients: challenges and perspectives
Pantel, K., & Alix-Panabières, C. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.001 · Cited by 815
Self-citationStrategies for discovering novel cancer biomarkers through utilization of emerging technologies
Kulasingam, V., & Diamandis, E. P. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1187 · Cited by 771
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Razavi, P., Li, B. T., Brown, D. N., Jung, B., Hubbell, E., Shen, R., Abida, W., Juluru, K., De Bruijn, I., Hou, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0652-7 · Cited by 769
Circulating Tumor DNA as a Liquid Biopsy for Cancer
Heitzer, E., Ulz, P., & Geigl, J. B. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.222679 · Cited by 767
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
Miyamoto, D. T., Zheng, Y., Wittner, B. S., Lee, R. J., Zhu, H., Broderick, K. T., Desai, R., Fox, D. B., Brannigan, B. W., Trautwein, J., et al. (2015) · Science · doi:10.1126/science.aab0917 · Cited by 705
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
Hodgkinson, C. L., Morrow, C. J., Li, Y., Metcalf, R. L., Rothwell, D. G., Trapani, F., Polanski, R., Burt, D. J., Simpson, K. L., Morris, K., et al. (2014) · Nature Medicine · doi:10.1038/nm.3600 · Cited by 694
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Lennon, A. M., Buchanan, A. H., Kinde, I., Warren, A., Honushefsky, A., Cohain, A. T., Ledbetter, D. H., Sanfilippo, F., Sheridan, K., Rosica, D., et al. (2020) · Science · doi:10.1126/science.abb9601 · Cited by 657
O'Leary, B., Cutts, R. J., Liu, Y., Hrebien, S., Huang, X., Fenwick, K., André, F., Loibl, S., Loi, S., Garcia-Murillas, I., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0264 · Cited by 650
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
Smerage, J. B., Barlow, W. E., Hortobagyi, G. N., Winer, E. P., Leyland-Jones, B., Srkalovic, G., Tejwani, S., Schott, A. F., O'Rourke, M. A., Lew, D. L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2561 · Cited by 648
Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
Rack, B., Schindlbeck, C., Jückstock, J., Andergassen, U., Hepp, P., Zwingers, T., Friedl, T. W. P., Lorenz, R., Tesch, H., Fasching, P. A., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju066 · Cited by 615
Self-citationScher, H. I., Jia, X., de Bono, J. S., Fleisher, M., Pienta, K. J., Raghavan, D., & Heller, G. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70340-1 · Cited by 611
Schiavon, G., Hrebien, S., Garcia-Murillas, I., Cutts, R. J., Pearson, A., Tarazona, N., Fenwick, K., Kozarewa, I., Lopez-Knowles, E., Ribas, R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7551 · Cited by 575
Lineage plasticity in cancer: a shared pathway of therapeutic resistance
Quintanal-Villalonga, Á., Chan, J. M., Yu, H. A., Pe’er, D., Sawyers, C. L., Sen, T., & Rudin, C. M. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0340-z · Cited by 572
Circulating tumor cell technologies
Ferreira, M. M., Ramani, V. C., & Jeffrey, S. S. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.007 · Cited by 511
Clinical utility of circulating non-coding RNAs — an update
Anfossi, S., Babayan, A., Pantel, K., & Calin, G. A. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0035-x · Cited by 450
Self-citationEarly stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection
Abbosh, C., Birkbak, N. J., & Swanton, C. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0058-3 · Cited by 450
Luo, H., Zhao, Q., Wei, W., Zheng, L., Yi, S., Li, G., Wang, W., Sheng, H., Pu, H., Mo, H., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7533 · Cited by 437
O’Leary, B., Hrebien, S., Morden, J. P., Beaney, M., Fribbens, C., Huang, X., Liu, Y., Bartlett, C. H., Koehler, M., Cristofanilli, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03215-x · Cited by 414
Douillard, J.-Y., Ostoros, G., Cobo, M., Ciuleanu, T., McCormack, R., Webster, A., & Milenkova, T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.721 · Cited by 412
Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?
Pantel, K., & Alix-Panabières, C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2030 · Cited by 409
Self-citationHER2 expression identifies dynamic functional states within circulating breast cancer cells
Jordan, N. V., Bardia, A., Wittner, B. S., Benes, C., Ligorio, M., Zheng, Y., Yu, M., Sundaresan, T. K., Licausi, J. A., Desai, R., et al. (2016) · Nature · doi:10.1038/nature19328 · Cited by 406
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
Keller, L., Belloum, Y., Wikman, H., & Pantel, K. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01047-5 · Cited by 401
Self-citationEstablishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells
Cayrefourcq, L., Mazard, T., Joosse, S., Solassol, J., Ramos, J., Assenat, E., Schumacher, U., Costes, V., Maudelonde, T., Pantel, K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2613 · Cited by 372
Self-citationDasari, A., Morris, V. K., Allegra, C. J., Atreya, C., Benson, A. B., Boland, P., Chung, K., Copur, M. S., Corcoran, R. B., Deming, D. A., et al. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0392-0 · Cited by 372
Moding, E. J., Liu, Y., Nabet, B. Y., Chabon, J. J., Chaudhuri, A. A., Hui, A. B., Bonilla, R. F., Ko, R. B., Yoo, C. H., Gojenola, L., et al. (2020) · Nature Cancer · doi:10.1038/s43018-019-0011-0 · Cited by 365
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
Janni, W. J., Rack, B., Terstappen, L. W. M. M., Pierga, J.-Y., Taran, F.-A., Fehm, T., Hall, C., de Groot, M. R., Bidard, F.-C., Friedl, T. W. P., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1603 · Cited by 363
Self-citationFehm, T., Müller, V., Aktas, B., Janni, W., Schneeweiss, A., Stickeler, E., Lattrich, C., Löhberg, C. R., Solomayer, E., Rack, B., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1163-x · Cited by 353
Self-citationExpression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
Gires, O., Pan, M., Schinke, H., Canis, M., & Baeuerle, P. A. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09898-3 · Cited by 351
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets
Best, M. G., Sol, N., In ‘t Veld, S. G. J. G., Vancura, A., Muller, M., Niemeijer, A.-L. N., Fejes, A. V., Tjon Kon Fat, L.-A., Huis In ‘t Veld, A. E., Leurs, C., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.004 · Cited by 343
Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer
Shaffer, D. R., Leversha, M. A., Danila, D. C., Lin, O., Gonzalez-Espinoza, R., Gu, B., Anand, A., Smith, K., Maslak, P., Doyle, G. V., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2701 · Cited by 338
Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma
Lee, J. H., Long, G. V., Boyd, S., Lo, S., Menzies, A. M., Tembe, V., Guminski, A., Jakrot, V., Scolyer, R. A., Mann, G. J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx026 · Cited by 333
Lee, J. H., Long, G. V., Menzies, A. M., Lo, S., Guminski, A., Whitbourne, K., Peranec, M., Scolyer, R., Kefford, R. F., Rizos, H., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.5332 · Cited by 315
Hofman, V., Ilie, M. I., Long, E., Selva, E., Bonnetaud, C., Molina, T., Vénissac, N., Mouroux, J., Vielh, P., & Hofman, P. (2011) · International Journal of Cancer · doi:10.1002/ijc.25819 · Cited by 304
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
Rothwell, D. G., Ayub, M., Cook, N., Thistlethwaite, F., Carter, L., Dean, E., Smith, N., Villa, S., Dransfield, J., Clipson, A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0380-z · Cited by 290
Mechanisms of nuclear content loading to exosomes
Yokoi, A., Villar-Prados, A., Oliphint, P. A., Zhang, J., Song, X., De Hoff, P., Morey, R., Liu, J., Roszik, J., Clise-Dwyer, K., et al. (2019) · Science Advances · doi:10.1126/sciadv.aax8849 · Cited by 289
Bidard, F.-C., Michiels, S., Riethdorf, S., Mueller, V., Esserman, L. J., Lucci, A., Naume, B., Horiguchi, J., Gisbert-Criado, R., Sleijfer, S., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy018 · Cited by 277
Self-citationAutio, K. A., Dreicer, R., Anderson, J., Garcia, J. A., Alva, A., Hart, L. L., Milowsky, M. I., Posadas, E. M., Ryan, C. J., Graf, R. P., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2168 · Cited by 275
Cristofanilli, M., Pierga, J.-Y., Reuben, J., Rademaker, A., Davis, A. A., Peeters, D. J., Fehm, T., Nolé, F., Gisbert-Criado, R., Mavroudis, D., et al. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.12.004 · Cited by 274
Self-citationUlz, P., Perakis, S., Zhou, Q., Moser, T., Belic, J., Lazzeri, I., Wölfler, A., Zebisch, A., Gerger, A., Pristauz, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12714-4 · Cited by 260
Circulating Epithelial Cells in Patients with Benign Colon Diseases
Pantel, K., Denève, E., Nocca, D., Coffy, A., Vendrell, J.-P., Maudelonde, T., Riethdorf, S., & Alix-Panabières, C. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.175570 · Cited by 255
Self-citationYokobori, T., Iinuma, H., Shimamura, T., Imoto, S., Sugimachi, K., Ishii, H., Iwatsuki, M., Ota, D., Ohkuma, M., Iwaya, T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-0326 · Cited by 249
Self-citationZimmer, L., Livingstone, E., Hassel, J. C., Fluck, M., Eigentler, T., Loquai, C., Haferkamp, S., Gutzmer, R., Meier, F., Mohr, P., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30417-7 · Cited by 243
Bidard, F.-C., Fehm, T., Ignatiadis, M., Smerage, J. B., Alix-Panabières, C., Janni, W., Messina, C., Paoletti, C., Müller, V., Hayes, D. F., et al. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9398-0 · Cited by 237
Self-citationGirotti, M. R., Gremel, G., Lee, R., Galvani, E., Rothwell, D., Viros, A., Mandal, A. K., Lim, K. H. J., Saturno, G., Furney, S. J., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1336 · Cited by 231
Heller, G., McCormack, R., Kheoh, T., Molina, A., Smith, M. R., Dreicer, R., Saad, F., de Wit, R., Aftab, D. T., Hirmand, M., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.2998 · Cited by 228
Capture of Viable Circulating Tumor Cells in the Liver of Colorectal Cancer Patients
Denève, E., Riethdorf, S., Ramos, J., Nocca, D., Coffy, A., Daurès, J.-P., Maudelonde, T., Fabre, J.-M., Pantel, K., & Alix-Panabières, C. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.202846 · Cited by 226
Self-citationAcquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
Van Emburgh, B. O., Arena, S., Siravegna, G., Lazzari, L., Crisafulli, G., Corti, G., Mussolin, B., Baldi, F., Buscarino, M., Bartolini, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms13665 · Cited by 214
Sparano, J., O’Neill, A., Alpaugh, K., Wolff, A. C., Northfelt, D. W., Dang, C. T., Sledge, G. W., & Miller, K. D. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2574 · Cited by 203
Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?
Hofman, P., Heeke, S., Alix-Panabières, C., & Pantel, K. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz196 · Cited by 200
Self-citationTumor Functional Heterogeneity Unraveled by scRNA-seq Technologies
González-Silva, L., Quevedo, L., & Varela, I. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2019.11.010 · Cited by 200
Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer
Lamb, Y. N., & Dhillon, S. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0259-y · Cited by 198
ctDNA monitoring using patient-specific sequencing and integration of variant reads
Wan, J. C. M., Heider, K., Gale, D., Murphy, S., Fisher, E., Mouliere, F., Ruiz-Valdepenas, A., Santonja, A., Morris, J., Chandrananda, D., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz8084 · Cited by 194
Rink, M., Chun, F. K., Dahlem, R., Soave, A., Minner, S., Hansen, J., Stoupiec, M., Coith, C., Kluth, L. A., Ahyai, S. A., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.01.017 · Cited by 190
Self-citationFluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
Leversha, M. A., Han, J., Asgari, Z., Danila, D. C., Lin, O., Gonzalez-Espinoza, R., Anand, A., Lilja, H., Heller, G., Fleisher, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2036 · Cited by 188
Scher, H. I., Graf, R. P., Schreiber, N. A., McLaughlin, B., Lu, D., Louw, J., Danila, D. C., Dugan, L., Johnson, A., Heller, G., et al. (2017) · European Urology · doi:10.1016/j.eururo.2016.11.024 · Cited by 182
Aggarwal, C., Meropol, N. J., Punt, C. J., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M. A., Mitchell, E., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds336 · Cited by 181
Bidard, F.-C., Jacot, W., Kiavue, N., Dureau, S., Kadi, A., Brain, E., Bachelot, T., Bourgeois, H., Gonçalves, A., Ladoire, S., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.5660 · Cited by 181
Self-citationRistau, B. T., O'Keefe, D. S., & Bacich, D. J. (2014) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.09.003 · Cited by 178
Establishment of tumor‐specific copy number alterations from plasma DNA of patients with cancer
Heitzer, E., Auer, M., Hoffmann, E. M., Pichler, M., Gasch, C., Ulz, P., Lax, S., Waldispuehl‐Geigl, J., Mauermann, O., Mohan, S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28030 · Cited by 175
Self-citationDecline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer
Lorente, D., Olmos, D., Mateo, J., Bianchini, D., Seed, G., Fleisher, M., Danila, D. C., Flohr, P., Crespo, M., Figueiredo, I., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.05.023 · Cited by 169
Lampignano, R., Neumann, M. H. D., Weber, S., Kloten, V., Herdean, A., Voss, T., Groelz, D., Babayan, A., Tibbesma, M., Schlumpberger, M., et al. (2020) · Clinical Chemistry · doi:10.1373/clinchem.2019.306837 · Cited by 162
Self-citationRadiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer
Siravegna, G., Lazzari, L., Crisafulli, G., Sartore-Bianchi, A., Mussolin, B., Cassingena, A., Martino, C., Lanman, R. B., Nagy, R. J., Fairclough, S., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.06.004 · Cited by 159
Castration-Resistant Prostate Cancer: From New Pathophysiology to New Treatment
Sridhar, S. S., Freedland, S. J., Gleave, M. E., Higano, C. S., Mulders, P., Parker, C. C., Sartor, O. A., & Fred Saad, C. (2013) · European Urology · doi:10.1016/j.eururo.2013.08.008 · Cited by 152
Alix‐Panabières, C. (2020) · Nature · doi:10.1038/d41586-020-00844-5 · Cited by 151
Self-citationEpithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells
Eslami‐S, Z., Cortés‐Hernández, L. E., & Alix‐Panabières, C. (2020) · Cells · doi:10.3390/cells9081836 · Cited by 151
Self-citationGröbe, A., Blessmann, M., Hanken, H., Friedrich, R. E., Schön, G., Wikner, J., Effenberger, K. E., Kluwe, L., Heiland, M., Pantel, K., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1101 · Cited by 149
Self-citationPresence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis
Trapp, E. K., Janni, W., Schindlbeck, C., Jückstöck, J., Andergassen, U., de Gregorio, A., Alunni‐Fabbroni, M., Tzschaschel, M. L. J., Polasik, A., Koch, J., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy152 · Cited by 149
Self-citationCirculating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility
Pantel, K., Hille, C., & Scher, H. I. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.287102 · Cited by 149
Self-citationGorges, T. M., Kuske, A., Roeck, K., Mauermann, O., Müller, V., Peine, S., Verpoort, K., Novosadová, V., Kubista, M., Riethdorf, S., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.260299 · Cited by 147
Self-citationGalanzha, E. I., Menyaev, Y. A., Yadem, A. C., Sarimollaoglu, M., Juratli, M. A., Nedosekin, D. A., Foster, S. R., Jamshidi‐Parsian, A., Siegel, E. R., Makhoul, I., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat5857 · Cited by 147
Marquette, C., Boutros, J., Benzaquen, J., Ferreira, M., Pastré, J., Pison, C. M., Padovani, B., Bettayeb, F., Fallet, V., Guibert, N. M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30081-3 · Cited by 147
Paoletti, C., Muñiz, M. C., Thomas, D. G., Griffith, K. A., Kidwell, K., Tokudome, N., Brown, M. E., Aung, K., Miller, M. C., Blossom, D. L., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1913 · Cited by 140
Buscail, É., Alix‐Panabières, C., Quincy, P., Cauvin, T., Chauvet, A., Degrandi, O., Caumont, C., Verdon, S., Lamrissi‐Garcia, I., Moranvillier, I., et al. (2019) · Cancers · doi:10.3390/cancers11111656 · Cited by 138
Self-citationScher, H. I., Graf, R. P., Schreiber, N. A., McLaughlin, B., Jendrisak, A., Wang, Y., Lee, J. S. H., Greene, S. B., Krupa, R., Lu, D. M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1353 · Cited by 137
Jiang, Y., Palma, J. F., Agus, D. B., Wang, Y., & Gross, M. E. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.143297 · Cited by 132
Hong, X., Sullivan, R. J., Kalinich, M., Kwan, T. T., Giobbie‐Hurder, A., Pan, S., LiCausi, J. A., Milner, J. D., Nieman, L. T., Wittner, B. S., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719264115 · Cited by 132
Babayan, A., Hannemann, J., Spötter, J., Müller, V., Pantel, K., & Joosse, S. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075038 · Cited by 129
Self-citationImproved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients
Kuske, A., Gorges, T. M., Tennstedt, P., Tiebel, A.-K., Pompe, R. S., Preißer, F., Prues, S., Mazel, M., Markou, A. N., Lianidou, E. S., et al. (2016) · Scientific Reports · doi:10.1038/srep39736 · Cited by 127
Self-citationCharacterization of circulating breast cancer cells with tumorigenic and metastatic capacity
Koch, C., Kuske, A., Joosse, S. A., Yigit, G., Sflomos, G., Thaler, S., Smit, D. J., Werner, S., Borgmann, K., Gärtner, S., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911908 · Cited by 125
Self-citationRamirez, J.-M., Fehm, T. N., Orsini, M., Cayrefourcq, L., Maudelondé, T., Pantel, K., & Alix‐Panabières, C. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.215079 · Cited by 124
Self-citationKim, T. H., Wang, Y., Oliver, C. R., Thamm, D. H., Cooling, L. L. W., Paoletti, C., Smith, K. J., Nagrath, S., & Hayes, D. F. (2019) · Nature Communications · doi:10.1038/s41467-019-09439-9 · Cited by 124
Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy
Chan, H. T., Nagayama, S., Chin, Y. M., Otaki, M., Hayashi, R., Kiyotani, K., Fukunaga, Y., Ueno, M., Nakamura, Y., & Low, S. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12727 · Cited by 122
Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
Tellez-Gabriel, M., Heymann, M., & Heymann, D. (2019) · Theranostics · doi:10.7150/thno.34337 · Cited by 119
Riethdorf, S., Müller, V., Loibl, S., Nekljudova, V., Weber, K., Huober, J., Fehm, T. N., Schrader, I., Hilfrich, J., Holms, F., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0255 · Cited by 116
Self-citationGazzaniga, P., BERARDINIS, E. D., Raimondi, C., Gradilone, A., Busetto, G. M., FALCO, E. D., Nicolazzo, C., Giovannone, R., Gentile, V., Cortesi, E., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28830 · Cited by 109
Self-citationCrosbie, P. A. J., Shah, R. D., Krysiak, P., Zhou, C., Morris, K. L., Tugwood, J. D., Booton, R., Blackhall, F. H., & Dive, C. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.06.017 · Cited by 108
Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer
Effenberger, K. E., Schroeder, C., Hanssen, A., Wolter, S., zu Eulenburg, C., Tachezy, M., Gebauer, F., Izbicki, J. R., Pantel, K., & Bockhorn, M. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0120 · Cited by 108
Self-citationGorges, T. M., Riethdorf, S., von Ahsen, O., Nastały, P., Roeck, K., Boede, M. O., Peine, S., Kuske, A., Schmid, E., Kneip, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9004 · Cited by 106
Self-citationFunctional Studies on Viable Circulating Tumor Cells
Pantel, K., & Alix‐Panabières, C. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.242537 · Cited by 96
Self-citationSoler, A., Cayrefourcq, L., Mazard, T., Babayan, A., Lamy, P., Assou, S., Assénat, E., Pantel, K., & Alix‐Panabières, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-34365-z · Cited by 92
Self-citationPancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target
Franses, J. W., Philipp, J., Missios, P., Bhan, I., Liu, A., Yashaswini, C. N., Tai, E. C., Zhu, H., Ligorio, M., Nicholson, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17150-3 · Cited by 91
Faugeroux, V., Pailler, E., Oulhen, M., Déas, O., Brullé, L., Hervieu, C., Marty, V., Alexandrova, K., Andree, K., Stoecklein, N. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15426-2 · Cited by 89
Cortés‐Hernández, L. E., Eslami‐S, Z., & Alix‐Panabières, C. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.07.008 · Cited by 88
Self-citationAntonarakis, E. S., Tagawa, S. T., Galletti, G., Worroll, D., Ballman, K. V., Vanhuyse, M., Sonpavde, G., North, S. A., Albany, C., Tsao, C., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.4138 · Cited by 85
Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma
Buscail, É., Maulat, C., Muscari, F., Chiche, L., Cordelier, P., Dabernat, S., Alix‐Panabières, C., & Buscail, L. (2019) · Cancers · doi:10.3390/cancers11060852 · Cited by 85
Self-citationAndree, K., Mentink, A., Zeune, L. L., Terstappen, L. W. M. M., Stoecklein, N. H., Neves, R. P., Driemel, C., Lampignano, R., Yang, L., Neubauer, H. J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31752 · Cited by 82
Haselmann, V., Gebhardt, C., Brechtel, I., Duda, A., Czerwinski, C., Sucker, A., Holland‐Letz, T., Utikal, J. S., Schadendorf, D., & Neumaier, M. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.281543 · Cited by 72
Alix‐Panabières, C., & Pantel, K. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1091729 · Cited by 60
Self-citationCirculating Tumor Cells in Patients with Testicular Germ Cell Tumors
Nastały, P., Ruf, C. G., Becker, P., Bednarz‐Knoll, N., Stoupiec, M., Kavsur, R., Hendrik Isbarn, A., Matthies, C., Wagner, W. P., Höppner, D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2819 · Cited by 60
Self-citationIn vivo acoustic and photoacoustic focusing of circulating cells
Galanzha, E. I., Viegas, M. G., Malinsky, T. I., Melerzanov, A., Juratli, M. A., Sarimollaoglu, M., Nedosekin, D. A., & Zharov, V. P. (2016) · Scientific Reports · doi:10.1038/srep21531 · Cited by 58
Circulating Tumor Cells: From the Laboratory to the Cancer Clinic
Agashe, R., & Kurzrock, R. (2020) · Cancers · doi:10.3390/cancers12092361 · Cited by 57
RNA-Seq of Circulating Tumor Cells in Stage II–III Breast Cancer
Lang, J. E., Ring, A., Porras, T. B., Kaur, P., Forte, V. A., Mineyev, N. M., Tripathy, D., Press, M. F., & Campo, D. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6540-4 · Cited by 55
Kita, K., Fukuda, K., Takahashi, H., Tanimoto, A., Nishiyama, A., Arai, S., Takeuchi, S., Yamashita, K., Ohtsubo, K., Otani, S., et al. (2019) · Cancer Science · doi:10.1111/cas.14171 · Cited by 51
Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma
Boyer, M., Cayrefourcq, L., Dereure, O., Meunier, L., Becquart, O., & Alix‐Panabières, C. (2020) · Cancers · doi:10.3390/cancers12040960 · Cited by 51
Self-citationS100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells
Cayrefourcq, L., de Roeck, A., Garcia, C. H., Stoebner, P., Fichel, F., Garima, F., Perriard, F., Daurès, J., Meunier, L., & Alix‐Panabières, C. (2019) · Cells · doi:10.3390/cells8070755 · Cited by 50
Self-citationDisseminated breast tumour cells: biological and clinical meaning
Pantel, K., & Hayes, D. F. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.174 · Cited by 47
Self-citationBuscail, É., Chiche, L., Laurent, C., Vendrely, V., Denost, Q., Denis, J. A., Thumerel, M., Lacorte, J., Bedel, A., Moreau‐Gaudry, F., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12534 · Cited by 47
Self-citationWerner, S., Brors, B., Eick, J., Marques, E., Pogenberg, V., Parret, A. H. A., Kemming, D., Wood, A. W., Edgren, H., Neubauer, H. J., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1042 · Cited by 46
Self-citationKoch, C., Joosse, S. A., Schneegans, S., Wilken, O. J. W., Janning, M., Loreth, D., Müller, V., Prieske, K., Banys-Paluchowski, M. J., Horst, L. J., et al. (2020) · Cancers · doi:10.3390/cancers12020442 · Cited by 43
Self-citationGorges, K., Wiltfang, L., Gorges, T. M., Sartori, A., Hildebrandt, L., Keller, L., Volkmer, B., Peine, S., Babayan, A., Moll, I., et al. (2019) · Cancers · doi:10.3390/cancers11111685 · Cited by 40
Self-citationEffenberger, K. E., Schroeder, C., zu Eulenburg, C., Reeh, M., Tachezy, M., Riethdorf, S., Vashist, Y. K., Izbicki, J. R., Pantel, K., & Bockhorn, M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26439 · Cited by 39
Self-citationCell-Free DNA Fragmentomics: The New “Omics” on the Block
Chiu, R. W. K., Heitzer, E., Lo, Y. M. D., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa258 · Cited by 38
Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma
Riethdorf, S., Hildebrandt, L., Heinzerling, L., Heitzer, E., Fischer, N., Bergmann, S., Mauermann, O., Waldispuehl‐Geigl, J., Coith, C., Schön, G., et al. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.297028 · Cited by 30
Self-citationDesigning circulating tumor DNA-based interventional clinical trials in oncology
Araújo, D. V., Bratman, S. V., & Siu, L. L. (2019) · Genome Medicine · doi:10.1186/s13073-019-0634-x · Cited by 30
Berger, L.-A., Janning, M., Velthaus, J.-L., Batalla, I. B., Schatz, S., Falk, M., Iglauer, P., Simon, R., Cao, R., Forcato, C., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.08.2025 · Cited by 23
Self-citationPSMA Theranostics Using PET and Subsequent Radioguided Surgery in Recurrent Prostate Cancer
Maurer, T., Schwamborn, K., Schottelius, M., et al. (2016) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2016.05.020 · Cited by 21
Seremet, T., Planken, S., Schreuer, M. S., Jansen, Y. J. L., Delaunoy, M., Housni, H. E., Líénard, D., del Mármol, V., Heimann, P., & Neyns, B. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000415 · Cited by 21
Bartkowiak, K., Koch, C., Gärtner, S., Andreas, A., Gorges, T. M., & Pantel, K. (2020) · Cells · doi:10.3390/cells9051316 · Cited by 17
Self-citationResponse to W.C. Taylor, and C. Fiala and E.P. Diamandis
Liu, M., Oxnard, G. R., Klein, E. A., Swanton, C., & Seiden, M. V. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.06.008 · Cited by 16
Circulating Tumor Cells in Head and Neck Carcinomas
Pantel, K. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.309609 · Cited by 7
Self-citationRao, A., & Antonarakis, E. S. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.92 · Cited by 5
Cited by
Breast cancer: pathogenesis and treatments
Xiong, X., Zheng, L.-W., Ding, Y., Chen, Y.-F., Cai, Y.-W., Wang, L.-P., Huang, L., Liu, C.-C., Shao, Z.-M., & Yu, K.-D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02108-4 · Cited by 958
Pascual, J., Attard, G., Bidard, F.-C., Curigliano, G., De Mattos-Arruda, L., Diehn, M., Italiano, A., Lindberg, J., Merker, J. D., Montagut, C., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.05.520 · Cited by 783
Self-citationLiquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 712
How to build the virtual cell with artificial intelligence: Priorities and opportunities
Bunne, C., Roohani, Y., Rosen, Y., Gupta, A., Zhang, X., Roed, M., Alexandrov, T., AlQuraishi, M., Brennan, P., Burkhardt, D. B., et al. (2024) · Cell · doi:10.1016/j.cell.2024.11.015 · Cited by 393
“141 Through the virtual cell’s implicit and structured representation of universal cell types and states, one can envision the creation of patient models of inaccessible cell types, such as beta cells in the pancreas or neurons in the brain, generated after sampling accessible cell types such as…”
Biology, vulnerabilities and clinical applications of circulating tumour cells
Ring, A., Nguyen-Sträuli, B. D., Wicki, A., & Aceto, N. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00536-4 · Cited by 327
Metadata
- Authors
- Alix-Panabières, C., & Pantel, K.
- Venue
- Cancer Discovery
- Published
- 2021-04-01
- Volume
- 11
- Issue
- 4
- Pages
- 858-873
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W3142541826
- Cited by
- 953
- References
- 150
- FWCI
- 52.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.